Equity
€2,500 from €171,151 in 2024
Equity fell by 99% in 1 year.
LVMB
Lifetime
6 annual accounts with figures on one time axispeak €249,052 (2025)
€249,052▲ 4.8%
peak €176,582 (2025)
€176,582▲ 4.7%
peak €171,151 (2024)
€2,500▼ 98.5%
€187,252▲ 15×
Board2 names since 2020
2 directors and 1 other
Documentsfilings and deeds
17-06-202644 days before the deadline
2025micro format
Dividend €345,233Equity from €171,151 to €2,500Debts from €12,810 to €187,252
Key points
from the 2025 annual accountsTurnover
≈ €460,000 estimated
The micro format states no turnover.
Debts
€187,252 99% of the balance sheet
Financial debts 4%Suppliers 0%Other 95%
Of this, €179,028 falls due within a year.
Liquidity
1.00 was 64.85 in 2024
Short-term debts rose from €2,578 to €179,028.
Filings
6 annual accounts 1 late
The 2021 accounts came 19 days late. The other five were filed on time.
Position in the sector
1.3%
Lower solvency than 94% of companies in human health. Sector median 63.1% · 21,330 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as LVMB has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for LVMB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 15-06-2020
Director, since 15-06-2020
- 50 sharesdeed of 18-06-2020
- 50 sharesdeed of 18-06-2020
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0748626994
Incorporation
Founding capital of €2,500, 100 shares · Founders: and · Appointments: (director) and (director) · published on 18-06-2020 · Gazette deed
First establishment
Ter Voortlaan 20, Edegem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| LVMB Edegem | €189,752 | €249,052 | 1.3% | - |
| Dr. BOONEN Eva Geel | €195,361 | €262,451 | 1.5% | - |
| DOKTER KAREN VAN VLIMMEREN ANESTHESIE Schilde | €194,717 | €244,506 | 94.4% | - |
| Claudia Bevers Oogarts Schilde | €216,582 | €246,904 | 1.2% | - |
| Dokter Len Verbeke, Gastro-Enterologie Antwerp | €201,486 | €224,887 | 85.7% | - |
| Dr. Stefanie Vandervelden Schoten | €177,471 | €229,619 | 5.6% | - |
| DR. JOHANNES GOEDEME Antwerp | €212,748 | €240,954 | 94.7% | - |
These companies have the same main activity as LVMB: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €177,000 and €217,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 16-06-2020Normal situation
- Activity
- Specialist medical practiceNACE 86220and 3 others
- Establishment unit
- 2.304.118.6972650 Edegem, since 16-06-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 02-09-2025
Annual accounts 2025
- €189,752▲ 3.1%
- Filing
- Filed on 17-06-2026, 44 days before the end of the filing period
Insights on LVMB
LVMB files the micro format. That format states no turnover. The gross margin rose from €43,468 in 2020 to €249,052 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LVMB
- What is the company number of LVMB?
- The company number of LVMB is 0748.626.994. The VAT number is the same number with BE in front: BE 0748.626.994.
- Where is LVMB based?
- The registered office is at Ter Voortlaan 20, 2650 Edegem.Company details
- What does LVMB do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of LVMB?
- LVMB is a private limited company (BV).
- When was LVMB founded?
- LVMB was founded on 16-06-2020.
- Is LVMB still active?
- Yes, LVMB is an active enterprise in the KBO register.
- What is the turnover of LVMB?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €249,052 and 40 comparable companies (NACE 86220). It probably lies between €390,000 and €620,000.Financials
- Is LVMB profitable?
- In financial year 2025, LVMB made a profit of €176,582.
- Where can I find the annual accounts of LVMB?
- LVMB filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LVMB due?
- LVMB must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.